NCT03740815

Brief Summary

INTRODUCTION: The axillary lymphadenectomy procedure is known to be associated with late postoperative complications, such as chronic pain and changes in shoulder mobility. Recently, several thoracic ultrasound guided interfascial blocks have been described, including serratus plane block. These blocks were associated with reduced postoperative pain scores in breast surgeries but were never evaluated in axillary dissection. The safety and feasibility of performing axillary dissection under local anesthesia and tumescent anesthesia associated with sedation has been demonstrated in case series, although it is not already the standard technique. DISCUSSION: This project aims to investigate the feasibility of the serratus plane block associated with intra-venous sedation in a prospective case series including 15 patients submitted to axillary dissection, by scoring patient and surgeon satisfaction with the technique, pain, quality of life with EORTC QLQ-C30 questionnaire, and quality of recovery with QoR-40 questionnaire in the first 30 postoperative days.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

September 25, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 14, 2018

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2021

Completed
Last Updated

April 8, 2022

Status Verified

August 1, 2021

Enrollment Period

2.4 years

First QC Date

June 25, 2018

Last Update Submit

March 30, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients who needed conversion to general anesthesia

    Percentage of patients who needed conversion to general anesthesia. A percentage from 0 to 100%, where 0% means that no patient needs technique conversion to general anesthesia and 100% means that all patients need it.

    Intraoperative

Secondary Outcomes (7)

  • The 30-item European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire.

    Preoperative and in Postoperative day 30

  • QoR-40 questionnaire

    Preoperative, First postoperative day visit and in Postoperative day 30

  • Surgeon satisfaction - 5 points Likert scale

    Imediate postoperative period

  • Patient satisfaction - 5 points Likert scale

    First postoperative day visit

  • Numeric pain rating scale (0-10)

    Preoperative, postoperative day 1 and 30

  • +2 more secondary outcomes

Study Arms (1)

Serratus plane block plus sedation

EXPERIMENTAL

Serratus plane block plus intravenous sedation as anesthetic technique during axillary dissection procedure.

Procedure: Serratus plane blockProcedure: Axillary dissectionProcedure: Intravenous sedation

Interventions

Ultrasound guided injection of local anesthetic between latissimus dorsi and serratus muscles at mid axillary line.

Serratus plane block plus sedation

Axillary dissection is a surgical procedure that incises the axilla to identify, examine, or remove lymph nodes.

Also known as: Axillary limphadenectomy
Serratus plane block plus sedation

Administration of sedatives thru an intravenous access to achieve relaxion and improve operative conditions.

Also known as: Sedation
Serratus plane block plus sedation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergo axillary dissection due to metastatic skin or soft tissue cancer;
  • ASA physical status classification between I and III;
  • have signed the informed consent.

You may not qualify if:

  • weight less than 40 kilograms;
  • tumor affecting topography to be blocked;
  • presence of ulcerated lesion in the axilla;
  • presence of coagulopathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital do Câncer II - National Cancer Institute of Brazil (INCA - Brazil)

Rio de Janeiro, Rio de Janeiro/RJ, 20220-410, Brazil

Location

Related Publications (18)

  • Fecho K, Miller NR, Merritt SA, Klauber-Demore N, Hultman CS, Blau WS. Acute and persistent postoperative pain after breast surgery. Pain Med. 2009 May-Jun;10(4):708-15. doi: 10.1111/j.1526-4637.2009.00611.x. Epub 2009 Apr 22.

    PMID: 19453965BACKGROUND
  • Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011 Jul;12(7):725-46. doi: 10.1016/j.jpain.2010.12.005. Epub 2011 Mar 24.

    PMID: 21435953BACKGROUND
  • Stoffels I, Dissemond J, Korber A, Hillen U, Poeppel T, Schadendorf D, Klode J. Reliability and cost-effectiveness of sentinel lymph node excision under local anaesthesia versus general anaesthesia for malignant melanoma: a retrospective analysis in 300 patients with malignant melanoma AJCC Stages I and II. J Eur Acad Dermatol Venereol. 2011 Mar;25(3):306-10. doi: 10.1111/j.1468-3083.2010.03786.x.

    PMID: 20626530BACKGROUND
  • Stoffels I, Dissemond J, Schulz A, Hillen U, Schadendorf D, Klode J. Reliability and cost-effectiveness of complete lymph node dissection under tumescent local anaesthesia vs. general anaesthesia: a retrospective analysis in patients with malignant melanoma AJCC stage III. J Eur Acad Dermatol Venereol. 2012 Feb;26(2):200-6. doi: 10.1111/j.1468-3083.2011.04036.x. Epub 2011 Mar 17.

    PMID: 21414036BACKGROUND
  • Pawa A, Wight J, Onwochei DN, Vargulescu R, Reed I, Chrisman L, Pushpanathan E, Kothari A, El-Boghdadly K. Combined thoracic paravertebral and pectoral nerve blocks for breast surgery under sedation: a prospective observational case series. Anaesthesia. 2018 Apr;73(4):438-443. doi: 10.1111/anae.14213. Epub 2018 Jan 12.

    PMID: 29327341BACKGROUND
  • Woodworth GE, Ivie RMJ, Nelson SM, Walker CM, Maniker RB. Perioperative Breast Analgesia: A Qualitative Review of Anatomy and Regional Techniques. Reg Anesth Pain Med. 2017 Sep/Oct;42(5):609-631. doi: 10.1097/AAP.0000000000000641.

    PMID: 28820803BACKGROUND
  • Kwekkeboom K. Postmastectomy pain syndromes. Cancer Nurs. 1996 Feb;19(1):37-43. doi: 10.1097/00002820-199602000-00005.

    PMID: 8904385BACKGROUND
  • Vecht CJ, Van de Brand HJ, Wajer OJ. Post-axillary dissection pain in breast cancer due to a lesion of the intercostobrachial nerve. Pain. 1989 Aug;38(2):171-6. doi: 10.1016/0304-3959(89)90235-2.

    PMID: 2780072BACKGROUND
  • Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012 Nov;59(9):470-5. doi: 10.1016/j.redar.2012.07.003. Epub 2012 Aug 29.

    PMID: 22939099BACKGROUND
  • Schnabel A, Reichl SU, Kranke P, Pogatzki-Zahn EM, Zahn PK. Efficacy and safety of paravertebral blocks in breast surgery: a meta-analysis of randomized controlled trials. Br J Anaesth. 2010 Dec;105(6):842-52. doi: 10.1093/bja/aeq265. Epub 2010 Oct 14.

    PMID: 20947592BACKGROUND
  • Blanco R, Parras T, McDonnell JG, Prats-Galino A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anaesthesia. 2013 Nov;68(11):1107-13. doi: 10.1111/anae.12344. Epub 2013 Aug 7.

    PMID: 23923989BACKGROUND
  • Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999 Sep 7;100(10):1043-9. doi: 10.1161/01.cir.100.10.1043.

    PMID: 10477528BACKGROUND
  • Jette M, Sidney K, Blumchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol. 1990 Aug;13(8):555-65. doi: 10.1002/clc.4960130809.

    PMID: 2204507BACKGROUND
  • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649-55. No abstract available.

    PMID: 7165009BACKGROUND
  • Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000 Jan;84(1):11-5. doi: 10.1093/oxfordjournals.bja.a013366.

    PMID: 10740540BACKGROUND
  • Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. doi: 10.1093/jnci/85.5.365.

    PMID: 8433390BACKGROUND
  • Franceschini J, Jardim JR, Fernandes AL, Jamnik S, Santoro IL. Reproducibility of the Brazilian Portuguese version of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire used in conjunction with its lung cancer-specific module. J Bras Pneumol. 2010 Sep-Oct;36(5):595-602. doi: 10.1590/s1806-37132010000500011. English, Portuguese.

    PMID: 21085825BACKGROUND
  • Agha RA, Fowler AJ, Rajmohan S, Barai I, Orgill DP; PROCESS Group. Preferred reporting of case series in surgery; the PROCESS guidelines. Int J Surg. 2016 Dec;36(Pt A):319-323. doi: 10.1016/j.ijsu.2016.10.025. Epub 2016 Oct 19.

    PMID: 27770639BACKGROUND

Related Links

MeSH Terms

Conditions

AgnosiaSkin Neoplasms

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeoplasms by SiteNeoplasmsSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Daniele Theobald, MD

    National Cancer Institute of Brazil (INCA - Brazil)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2018

First Posted

November 14, 2018

Study Start

September 25, 2018

Primary Completion

March 2, 2021

Study Completion

March 2, 2021

Last Updated

April 8, 2022

Record last verified: 2021-08

Locations